Myers Diane 4
4 · Recro Pharma, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
Myers Diane
Senior VP-Reg./Quality
Transactions
- Tax Payment
Common Stock
2017-09-28$9.04/sh−2,480$22,419→ 8,803 total - Exercise/Conversion
Common Stock
2017-09-28+8,000→ 11,283 total
Footnotes (1)
- [F1]On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 8,000 performance-based restricted stock units, which were converted into 8,000 shares of common stock on a one-for-one basis.